American Association for the Advancement of Science, Science Translational Medicine, 491(11), 2019
DOI: 10.1126/scitranslmed.aau1167
Full text: Unavailable
Targeting oxidative phosphorylation overcomes ibrutinib resistance in mantle cell lymphoma.